ASCOLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 653
AS - Asia 362
EU - Europa 262
SA - Sud America 72
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.356
Nazione #
US - Stati Uniti d'America 634
SG - Singapore 207
IT - Italia 94
CN - Cina 66
BR - Brasile 55
DE - Germania 39
IN - India 37
FI - Finlandia 32
GB - Regno Unito 19
VN - Vietnam 19
HK - Hong Kong 18
SE - Svezia 18
EE - Estonia 17
AR - Argentina 10
MX - Messico 9
AT - Austria 8
CA - Canada 6
FR - Francia 6
BD - Bangladesh 4
ES - Italia 4
NL - Olanda 4
PL - Polonia 4
RU - Federazione Russa 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
JP - Giappone 3
BE - Belgio 2
HN - Honduras 2
IE - Irlanda 2
KR - Corea 2
SA - Arabia Saudita 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
RS - Serbia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 1.356
Città #
Dallas 274
Singapore 124
Chandler 58
Munich 34
Bengaluru 32
Santa Clara 28
Hefei 25
Ashburn 22
Turku 22
Milan 19
Hong Kong 18
Lawrence 15
London 15
Princeton 15
Beijing 12
Chicago 12
Boardman 11
Wilmington 11
Genoa 10
Helsinki 10
Hanoi 6
Ho Chi Minh City 6
Los Angeles 5
São Paulo 5
Atlanta 4
Des Moines 4
Johannesburg 4
Mexico City 4
Phoenix 4
Seattle 4
Warsaw 4
West Jordan 4
Boston 3
Brooklyn 3
Busto Arsizio 3
Chennai 3
Ferrara 3
Mission 3
Olomouc 3
Padova 3
San Francisco 3
Shanghai 3
Tokyo 3
Valmadrera 3
Angri 2
Assago 2
Curitiba 2
Denver 2
Dhaka 2
Dublin 2
Guangzhou 2
Guayaquil 2
Haiphong 2
Hangzhou 2
Hanover 2
Joinville 2
León 2
Louisville 2
Manaus 2
Manchester 2
New York 2
Romainville 2
San Jose 2
Seoul 2
São Francisco de Itabapoana 2
Turin 2
Vicenza 2
Vienna 2
Zacatecas City 2
Zola Predosa 2
Abidjan 1
Addis Ababa 1
Alexandria 1
Amman 1
Ann Arbor 1
Araguatins 1
Barnaul 1
Belgrade 1
Benito Juarez 1
Bogotá 1
Bologna 1
Botucatu 1
Brasília 1
Brusque 1
Brussels 1
Buenos Aires 1
Buffalo 1
Campos dos Goytacazes 1
Carapicuíba 1
Carmagnola 1
Carney 1
Cassano d'Adda 1
Catania 1
Catanzaro 1
Caxambu 1
Charlotte 1
Clorinda 1
Coesfeld 1
Columbus 1
Council Bluffs 1
Totale 939
Nome #
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 128
A comprehensive machine-learning-based software pipeline to classify EEG signals: A case study on PNES vs. control subjects 107
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 69
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 58
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 58
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 50
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 50
Epidemiology and outcomes of status epilepticus 47
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 46
Therapeutic approach to neurological manifestations of Angelman syndrome 46
Dystonia in Angelman syndrome: a common, unrecognized clinical finding 46
Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes 46
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy 44
Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome 41
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures 40
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 39
Effectiveness of Perampanel as the Only Add-on: Retrospective, Multicenter, Observational Real Life Study on epilepsy patients 37
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study 36
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy 36
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 35
Self-induced psychogenic non-epileptic seizure. A case report 35
Functional convergence spasm: An unexpected finding in a patient with focal epilepsy 34
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 34
null 33
Younger age at stroke onset but not thrombolytic treatment predicts poststroke epilepsy: An updated meta-analysis 33
Management of status epilepticus in patients with liver or kidney disease: a narrative review 33
Epileptogenic role of occult temporal encephalomeningocele 32
Novel COL4A2 mutation causing familial malformations of cortical development 31
The relevance of MRI blood-sensitive sequences in the diagnostic assessment of late-onset epilepsy 28
Proprioceptive-induced seizures in non-ketotic hyperglycemia. A video-EEG documentation 26
SMART: stroke-like migraine attacks after radiation therapy or seizures with migraine-like attacks after radiation therapy? Terms do matter in clinical practice 25
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) 3
Totale 1.406
Categoria #
all - tutte 10.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.751


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 2 7 1 0 0
2021/202265 0 0 3 22 1 0 3 14 8 7 7 0
2022/2023159 33 2 15 11 14 19 1 12 22 12 14 4
2023/202497 16 16 3 11 5 16 8 2 1 5 6 8
2024/2025418 33 22 23 25 35 75 23 7 18 23 56 78
2025/2026648 55 80 275 191 47 0 0 0 0 0 0 0
Totale 1.406